Election 2024: State Health Care Snapshots

These fact sheets lay out the health care landscape in every state, providing data on a variety of health care topics that may be the focus of policy debates in the 2024 election. Topics include health costs; women’s health policy, including state abortion, contraception and maternity laws and policies; health coverage, including the Affordable Care…

Read More

Immigration Detention Center Contractor Sues Over California Health Inspections

GEO Group, one of the nation’s largest private prison contractors, filed a federal lawsuit last month against California officials to strike down a state law allowing local public health officials to inspect immigration detention facilities. The Florida-based company argued in a filing that California’s law, signed by Gov. Gavin Newsom in August, is unconstitutional because…

Read More

Will HHS Enhance or Stall the Promise of Artificial Intelligence for Healthcare?

By STEVEN ZECOLA In its Strategy for Artificial Intelligence (V.3), the Department of Health and Human Services (“HHS”) acknowledges that: “For too long, our Department has been bogged down by bureaucracy and busy work.” HHS promises that it will accelerate artificial intelligence (“AI”) innovation, including “accelerating drug and biologic approvals at the FDA.” History shows…

Read More

Five Ways Technology Can Transform Chronic Care Management

When paired with clinician-led care, it enables a fundamentally different approach to chronic disease management. These tools are designed to augment care teams by reducing administrative burden and allowing clinicians to focus on higher-value care.  The post Five Ways Technology Can Transform Chronic Care Management appeared first on MedCity News.

Read More

A deeper dive into drug revenue and cost

Many people don’t understand why pharmaceuticals cost so much money. Don’t pharmaceutical companies make a lot of money? The answer is ‘yes’, but only if the drugs are successful. A paper by Wouters et al. (2024) found that: Based on data for 361 of 558 new therapeutic agents approved over the study period (median follow-up…

Read More